CD8A and Alzheimer disease: Blocking the interaction of T cell VLA-4 and vascular endothelial cell VCAM-1 by antibodies can effectively reduce the infiltration of CD4+ and CD8+ T cells into the brain parenchyma of 3×Tg-AD mice, and reduce the deposition of Aβ and the phosphorylation of Tau[114].